We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Frontotemporal dementia: diagnosis, deficits and management

    Nicholas T Bott

    *Author for correspondence:

    E-mail Address: nbott@stanford.edu

    Department of Neurology, Memory & Aging Center, University of California, 675 Nelson Rising Lane, Suite 190, San Francisco, CA 94158, USA

    ,
    Anneliese Radke

    Department of Neurology, Memory & Aging Center, University of California, 675 Nelson Rising Lane, Suite 190, San Francisco, CA 94158, USA

    ,
    Melanie L Stephens

    Department of Neurology, Memory & Aging Center, University of California, 675 Nelson Rising Lane, Suite 190, San Francisco, CA 94158, USA

    &
    Joel H Kramer

    Department of Neurology, Memory & Aging Center, University of California, 675 Nelson Rising Lane, Suite 190, San Francisco, CA 94158, USA

    Published Online:https://doi.org/10.2217/nmt.14.34

    SUMMARY 

    Frontotemporal dementia (FTD) is a progressive neurologic syndrome with diverse clinical presentations and attendant underlying pathologies. Psychiatric prodrome, neuropsychiatric symptoms and language difficulties are common in FTD, but the diversity of presentation raises unique diagnostic challenges that can significantly impact patient care and counsel for caregivers regarding clinical status and prognosis. While neuropsychiatric symptom measures are helpful, more sensitive assessments delineating the specific behavioral and linguistic deficits accompanying FTD are needed. Comprehensive clinical assessment in combination with evaluation of language, socio-emotional functioning, cognition and neuroimaging aid in accurate and early diagnosis and treatment planning. In what follows, we review each of the FTD syndromes, highlight current research investigating the cognitive, behavioral and socio-emotional deficits observed with this disease, address common diagnostic challenges and summarize best practices associated with management of FTD.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1 Brunnstrom H, Gustafson L, Passant U et al. Prevalence of dementia subtypes: a 30-year retrospective survey of neuropathological reports. Arch. Gerontol. Geriatr. 49(1), 146–149 (2009).
    • 2 Johnson JK, Diehl J, Mendez MF et al. Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch. Neurol. 62(6), 925–930 (2005).
    • 3 Ratnavalli E, Brayne C, Dawson K et al. The prevalence of frontotemporal dementia. Neurology 58(11), 1615–1621 (2002).
    • 4 Pasquier F, Petit H. Frontotemporal dementia: its rediscovery. Eur. Neurol. 38(1), 1–6 (1997).
    • 5 Perry RJ, Graham A, Williams G et al. Patterns of frontal lobe atrophy in frontotemporal dementia: a volumetric MRI study. Dement. Geriatr. Cogn. Disord. 22(4), 278–287 (2006).
    • 6 Rabinovici GD, Miller BL. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs 24(5), 375–398 (2010).
    • 7 Gorno-Tempini ML, Hillis AE, Weintraub S et al. Classification of primary progressive aphasia and its variants. Neurology 76(11), 1006–1014 (2011).•• Provides the new framework for the classification and diagnosis of primary progressive aphasia (PPA) subtypes.
    • 8 Rankin KP, Baldwin E, Pace-Savitsky C et al. Self-awareness and personality change in dementia. J. Neurol. Neurosurg. Psychiatry 76(5), 632–639 (2005).
    • 9 Thompson SA, Patterson K, Hodges JR. Left/right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications. Neurology 61(9), 1196–1203 (2003).
    • 10 Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int. Rev. Psychiatry 25(2), 130–137 (2013).
    • 11 Mioshi E, Kipps CM, Dawson K et al. Activities of daily living in frontotemporal dementia and Alzheimer disease. Neurology 68(24), 2077–2084 (2007).
    • 12 Roberson ED, Hesse JH, Rose KD et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 65(5), 719–725 (2005).
    • 13 Rascovsky K, Salmon DP, Lipton AM et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology 65(3), 397–403 (2005).
    • 14 Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch. Gerontol. Geriatr. 6(3), 193–208 (1987).
    • 15 Mackenzie IR, Neumann M, Bigio EH et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119(1), 1–4 (2010).
    • 16 Snowden J, Neary D, Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 114(1), 31–38 (2007).
    • 17 Rohrer JD, Rosen HJ. Neuroimaging in frontotemporal dementia. Int. Rev. Psychiatry 25(2), 221–229 (2013).• Provides a review of current techniques and findings in neuroimaging studies of frontotemporal dementia (FTD) subtypes.
    • 18 Mackenzie IR, Foti D, Woulfe J et al. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain 131(Pt 5), 1282–1293 (2008).
    • 19 Neumann M, Rademakers R, Roeber S et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132(Pt 11), 2922–2931 (2009).
    • 20 Hodges JR, Mitchell J, Dawson K et al. Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain 133(Pt 1), 300–306 (2010).
    • 21 Shi J, Shaw CL, Du Plessis D et al. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol. 110(5), 501–512 (2005).
    • 22 Rosso SM, Donker Kaat L, Baks T et al. Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126(Pt 9), 2016–2022 (2003).
    • 23 Goldman JS, Farmer JM, Wood EM et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 65(11), 1817–1819 (2005).
    • 24 Rohrer JD, Guerreiro R, Vandrovcova J et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology 73(18), 1451–1456 (2009).
    • 25 Whitwell JL, Jack CR, Jr., Boeve BF et al. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology 72(9), 813–820 (2009).
    • 26 Snowden JS, Rollinson S, Thompson JC et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135(Pt 3), 693–708 (2012).
    • 27 Majounie E, Abramzon Y, Renton AE et al. Repeat expansion in C9ORF72 in Alzheimer's disease. N. Engl. J. Med. 366(3), 283–284 (2012).
    • 28 Sha SJ, Takada LT, Rankin KP et al. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology 79(10), 1002–1011 (2012).
    • 29 Baker M, Mackenzie IR, Pickering-Brown SM et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442(7105), 916–919 (2006).
    • 30 Bettcher BM, Kramer JH. Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship. Neurocase 19(2), 182–200 (2013).
    • 31 Boxer AL, Gold M, Huey E et al. Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement. 9(2), 176–188 (2013).
    • 32 Lee BS, Jun IG, Kim SH et al. Intrathecal gabapentin increases interleukin-10 expression and inhibits pro-inflammatory cytokine in a rat model of neuropathic pain. J. Korean Med. Sci. 28(2), 308–314 (2013).
    • 33 Tang W, Lu Y, Tian QY et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332(6028), 478–484 (2011).
    • 34 Miller ZA, Rankin KP, Graff-Radford NR et al. TDP-43 frontotemporal lobar degeneration and autoimmune disease. J. Neurol. Neurosurg. Psychiatry 84(9), 956–962 (2013).
    • 35 Miller ZA, Mandelli ML, Rankin KP et al. Handedness and language learning disability differentially distribute in progressive aphasia variants. Brain 136(Pt 11), 3461–3473 (2013).
    • 36 Rogalski E, Johnson N, Weintraub S et al. Increased frequency of learning disability in patients with primary progressive aphasia and their first-degree relatives. Arch. Neurol. 65(2), 244–248 (2008).
    • 37 Sollberger M, Neuhaus J, Ketelle R et al. Interpersonal traits change as a function of disease type and severity in degenerative brain diseases. J. Neurol. Neurosurg. Psychiatry 82(7), 732–739 (2011).
    • 38 Seeley WW, Crawford R, Rascovsky K et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch. Neurol. 65(2), 249–255 (2008).
    • 39 Seeley WW. Selective functional, regional, and neuronal vulnerability in frontotemporal dementia. Curr. Opin. Neurol. 21(6), 701–707 (2008).
    • 40 Snowden JS, Bathgate D, Varma A et al. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J. Neurol. Neurosurg. Psychiatry 70(3), 323–332 (2001).
    • 41 Bozeat S, Gregory CA, Ralph MA et al. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J. Neurol. Neurosurg. Psychiatry 69, 178–186 (2000).
    • 42 Postiglione A, Milan G, Pappata S et al. Fronto-temporal dementia presenting as Geschwind's syndrome. Neurocase 14(3), 264–270 (2008).
    • 43 Manes FF, Torralva T, Roca M et al. Frontotemporal dementia presenting as pathological gambling. Nat. Rev. Neurol. 6(6), 347–352 (2010).
    • 44 Hornberger M, Shelley BP, Kipps CM et al. Can progressive and non-progressive behavioral variant frontotemporal dementia be distinguished at presentation? J. Neurol. Neurosurg. Psychiatry 80(6), 591–593 (2009).
    • 45 Davies RR, Kipps CM, Mitchell J et al. Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch. Neurol. 63(11), 1627–1631 (2006).
    • 46 Piguet O, Hornberger M, Mioshi E et al. Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol. 10(2), 162–172 (2011).
    • 47 Kipps CM, Hodges JR, Fryer TD et al. Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype. Brain 132(Pt9), 2566–2578 (2009).
    • 48 Kipps CM, Hodges JR, Hornberger M. Nonprogressive behavioural frontotemporal dementia: recent developments and clinical implications of the ‘bvFTD phenocopy syndrome’. Curr. Opin Neurol. 23(6), 628–632 (2010).
    • 49 Rosen HJ, Narvaez JM, Hallam B et al. Neuropsychological and functional measures of severity in Alzheimer disease, frontotemporal dementia, and semantic dementia. Alzheimer Dis. Assoc. Disord. 18(4), 202–207 (2004).
    • 50 Wicklund AH, Johnson N, Rademaker A et al. Profiles of decline in activities of daily living in non-Alzheimer dementia. Alzheimer Dis. Assoc. Disord. 21(1), 8–13 (2007).
    • 51 Rosen HJ, Allison SC, Schauer GF et al. Neuroanatomical correlates of behavioural disorders in dementia. Brain 128(Pt 11), 2612–2625 (2005).
    • 52 Turk K, Dugan E. Research brief: a literature review of frontotemporal dementia and driving. Am. J. Alzheimers Dis. Other Demen. PMID:24413539, doi:10.1177/1533317513518656 (2014) (Epub ahead of print).
    • 53 Hornberger M, Piguet O, Graham AJ et al. How preserved is episodic memory in behavioral variant frontotemporal dementia? Neurology 74(6), 472–479 (2010).
    • 54 Hornberger M, Piguet O, Kipps C et al. Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia. Neurology 71(19), 1481–1488 (2008).
    • 55 Possin KL, Lamarre AK, Wood KA et al. Ecological validity and neuroanatomical correlates of the NIH EXAMINER executive composite score. J. Int. Neuropsychol Soc. 20(1), 20–28 (2014).
    • 56 Larner, AJ. Can the Frontal Assessment Battery (FAB) help in the diagnosis of behavioural variant frontotemporal dementia? A pragmatic study. Int. J. Geriatr. Psychiatry 28(1), 106–107 (2013).
    • 57 Possin KL, Brambati SM, Rosen HJ et al. Rule violation errors are associated with right lateral prefrontal cortex atrophy in neurodegenerative disease. J. Int. Neuropsychol Soc. 15(3), 354–364 (2009).
    • 58 Rankin KP, Gorno-Tempini ML, Allison SC et al. Structural anatomy of empathy in neurodegenerative disease. Brain 129(Pt 11), 2945–2956 (2006).
    • 59 Sollberger M, Rosen HJ, Shany-Ur T et al. Neural substrates of socioemotional self-awareness in neurodegenerative disease. Brain Behav. 4(2), 201–214 (2014).
    • 60 Lough S, Kipps CM, Treise C, Watson P, Blair JR, Hodges JR. Social reasoning, emotion and empathy in frontotemporal dementia. Neuropsychologia 44(6), 950–958 (2006).
    • 61 Fernandez-Duque D, Black SE. Impaired recognition of negative facial emotions in patients with frontotemporal dementia. Neuropsychologia 43(11), 1673–1687 (2005).
    • 62 Shany-Ur T, Poorzand P, Grossman SN et al. Comprehension of insincere communication in neurodegenerative disease: lies, sarcasm, and theory of mind. Cortex 48(10), 1329–1341 (2012).
    • 63 Rosen HJ, Alcantar O, Zakrzewski J et al. Metacognition in the behavioral variant of frontotemporal dementia and Alzheimer's disease. Neuropsychology 28(3), 436–447 (2014).
    • 64 Chiong W, Wilson SM, D'esposito M et al. The salience network causally influences default mode network activity during moral reasoning. Brain 136(Pt 6), 1929–1941 (2013).
    • 65 Kumfor F, Irish M, Leyton C et al. Tracking the progression of social cognition in neurodegenerative disorders. J. Neurol. Neurosurg. Psychiatry doi:10.1136jnnp-2013307098 (2014) (Epub ahead of print).
    • 66 Perry DC, Sturm VE, Wood KA et al. Divergent processing of monetary and social reward in behavioral variant frontotemporal dementia and Alzheimer disease. Alzheimer Dis. Assoc. Disord. doi:10.1097/WAD.0000000000000012 (2013) (Epub ahead of print).
    • 67 Rahman S, Sahakian BJ, Hodges JR et al. Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain 122(Pt 8), 1469–1493 (1999).
    • 68 Torralva T, Kipps CM, Hodges JR et al. The relationship between affective decision-making and theory of mind in the frontal variant of fronto-temporal dementia. Neuropsychologia 45(2), 342–349 (2007).
    • 69 Bechara A, Damasio AR, Damasio H et al. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50(1–3), 7–15 (1994).
    • 70 Shinagawa S, Ikeda M, Nestor PJ et al. Characteristics of abnormal eating behaviours in frontotemporal lobar degeneration: a cross-cultural survey. J. Neurol. Neurosurg. Psychiatry 80(12), 1413–1414 (2009).
    • 71 Woolley JD, Khan BK, Natesan A et al. Satiety-related hormonal dysregulation in behavioral variant frontotemporal dementia. Neurology 82(6), 512–520 (2014).
    • 72 Rascovsky K, Hodges JR, Knopman D et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(Pt 9), 2456–2477 (2011).•• Provides the new framework for the classification and diagnosis of behavioral variant FTD (bvFTD).
    • 73 Lamarre AK, Rascovsky K, Bostrom A et al. Interrater reliability of the new criteria for behavioral variant frontotemporal dementia. Neurology 80(21), 1973–1977 (2013).
    • 74 Gorno-Tempini ML, Dronkers NF, Rankin KP et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann. Neurol. 55(3), 335–346 (2004).• Provides comprehensive information regarding the cognitive deficits and underlying patterns of neurodegeneration for each of the PPA subtypes.
    • 75 Hodges JR, Patterson K, Oxbury S et al. Semantic dementia: progressive fluent aphasia with temporal lobe atrophy. Brain 115(Pt 6), 1783–1806 (1992).
    • 76 Seeley WW, Bauer AM, Miller BL et al. The natural history of temporal variant frontotemporal dementia. Neurology 64(8), 1384–1390 (2005).
    • 77 Snowden JS, Thompson JC, Neary D. Knowledge of famous faces and names in semantic dementia. Brain 127(Pt 4), 860–872 (2004).
    • 78 Henry ML, Wilson SM, Ogar JM et al. Neuropsychological, behavioral, and anatomical evolution in right temporal variant frontotemporal dementia: a longitudinal and post-mortem single case analysis. Neurocase 20(1), 100–109 (2014).
    • 79 Rosen HJ, Allison SC, Ogar JM et al. Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology 67(10), 1752–1756 (2006).
    • 80 Rosen HJ, Gorno-Tempini ML, Goldman WP et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58(2), 198–208 (2002).
    • 81 Wu TQ, Miller ZA, Adhimoolam B et al. Verbal creativity in semantic variant primary progressive aphasia. Neurocase doi:10.1080/13554794.2013.860179 (2013) (Epub ahead of print).
    • 82 Chatterjee A. The neuropsychology of visual artistic production. Neuropsychologia 42(11), 1568–1583 (2004).
    • 83 Miller BL, Cummings J, Mishkin F et al. Emergence of artistic talent in frontotemporal dementia. Neurology 51(4), 978–982 (1998).
    • 84 Mioshi E, Hsieh S, Savage S et al. Clinical staging and disease progression in frontotemporal dementia. Neurology 74(20), 1591–1597 (2010).
    • 85 Mioshi E, Hodges JR. Rate of change of functional abilities in frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 28(5), 419–426 (2009).
    • 86 O'connor C, Ahmed S, Mioshi E. Functional disability in primary progressive aphasia. Aphasiology 28(8–9), 1131–1149 (2014).• Describes the patterns of functional disability associated with each of the PPA subtypes and provides recommendations for strategies addressing specific functional impairments.
    • 87 Perry RJ, Hodges JR. Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease. Neurology 54(12), 2277–2284 (2000).
    • 88 Shim H, Hurley RS, Rogalski E et al. Anatomic, clinical, and neuropsychological correlates of spelling errors in primary progressive aphasia. Neuropsychologia 50(8), 1929–1935 (2012).
    • 89 Kertesz A, Davidson W, Mccabe P. Primary progressive semantic aphasia: a case study. J. Int. Neuropsychol Soc. 4(4), 388–398 (1998).
    • 90 Kertesz A, Jesso S, Harciarek M et al. What is semantic dementia?: a cohort study of diagnostic features and clinical boundaries. Arch. Neurol. (67), 483–489 (2010).
    • 91 Mychack P, Kramer JH, Boone KB et al. The influence of right frontotemporal dysfunction on social behavior in frontotemporal dementia. Neurology 56(11 Suppl 4), S11–15 (2001).
    • 92 Irish M, Hodges JR, Piguet O. Right anterior temporal lobe dysfunction underlies theory of mind impairments in semantic dementia. Brain 137(Pt 4), 1241–1253 (2014).
    • 93 Knibb JA, Woollams AM, Hodges JR et al. Making sense of progressive non-fluent aphasia: an analysis of conversational speech. Brain 132(Pt 10), 2734–2746 (2009).
    • 94 Grossman M. The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol. 11(6), 545–555 (2012).
    • 95 Gorno-Tempini ML, Ogar JM, Brambati SM et al. Anatomical correlates of early mutism in progressive nonfluent aphasia. Neurology 67(10), 1849–1851 (2006).
    • 96 Wilson SM, Henry ML, Besbris M et al. Connected speech production in three variants of primary progressive aphasia. Brain 133(Pt 7), 2069–2088 (2010).
    • 97 Mesulam MM, Grossman M, Hillis A et al. The core and halo of primary progressive aphasia and semantic dementia. Ann. Neurol. 54(Suppl 5), S11–14 (2003).
    • 98 Le Rhun E, Richard F, Pasquier F. Natural history of primary progressive aphasia. Neurology 65(6), 887–891 (2005).
    • 99 Seeley WW, Matthews BR, Crawford RK et al. Unraveling Bolero: progressive aphasia, transmodal creativity and the right posterior neocortex. Brain (131), 39–49 (2008).
    • 100 Jang J, Cushing N, Clemson L et al. Activities of daily living in progressive non-fluent aphasia, logopenic progressive aphasia and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 33(5), 354–360 (2012).
    • 101 Harciarek M, Sitek EJ, Kertesz A. The patterns of progression in primary progressive aphasia: implications for assessment and management. Aphasiology 28(8–9), 964–980 (2014).• Summarizes current knowledge regarding the assessment, course and management of PPA subtypes.
    • 102 Libon DJ, Xie SX, Moore P et al. Patterns of neuropsychological impairment in frontotemporal dementia. Neurology 68(5), 369–375 (2007).
    • 103 Murray R, Neumann M, Forman MS et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 68(16), 1274–1283 (2007).
    • 104 Rohrer JD, Sauter D, Scott S et al. Receptive prosody in nonfluent primary progressive aphasias. Cortex 48(3), 308–316 (2012).
    • 105 Shany-Ur T, Rankin KP. Personality and social cognition in neurodegenerative disease. Curr. Opin Neurol. 24(6), 550–555 (2011).• Summarizes current knowledge of personality change and social cognition deficits in neurodegenerative disease, including each of the FTD subtypes.
    • 106 Couto B, Manes F, Montanes P et al. Structural neuroimaging of social cognition in progressive non-fluent aphasia and behavioral variant of frontotemporal dementia. Front. Hum. Neurosci. 7, 467 (2013).
    • 107 Woolley JD, Khan BK, Murthy NK et al. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J. Clin. Psychiatry 72(2), 126–133 (2011).• Provides evidence that patients diagnosed with bvFTD are often previously diagnosed with psychiatric diseases.
    • 108 Rosness TA, Haugen PK, Passant U et al. Frontotemporal dementia: a clinically complex diagnosis. Int. J. Geriatr. Psychiatry 23(8), 837–842 (2008).
    • 109 Pose M, Cetkovich M, Gleichgerrcht E et al. The overlap of symptomatic dimensions between frontotemporal dementia and several psychiatric disorders that appear in late adulthood. Int. Rev. Psychiatry 25(2), 159–167 (2013).
    • 110 Devenney E, Hornberger M, Irish M et al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol. 71(3), 331–339 (2014).
    • 111 Byrne S, Heverin M, Elamin M et al. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Ann. Neurol. 74(5), 699–708 (2013).
    • 112 Kertesz A, Mcmonagle P, Blair M et al. The evolution and pathology of frontotemporal dementia. Brain 128(Pt 9), 1996–2005 (2005).
    • 113 Rankin KP, Mayo MC, Seeley WW et al. Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease. J. Mol. Neurosci. 45(3), 594–608 (2011).
    • 114 Lee SE, Rabinovici GD, Mayo MC et al. Clinicopathological correlations in corticobasal degeneration. Ann. Neurol. 70(2), 327–340 (2011).
    • 115 Chiu WZ, Papma JM, De Koning I et al. Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 83(9), 910–915 (2012).
    • 116 Taylor KI, Probst A, Miserez AR et al. Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease. Nat. Clin. Pract. Neurol. 4(4), 226–232 (2008).
    • 117 Woodward M, Jacova C, Black SE et al. Differentiating the frontal variant of Alzheimer's disease. Int. J. Geriatr. Psychiatry 25(7), 732–738 (2010).
    • 118 Blennerhassett R, Lillo P, Halliday GM et al. Distribution of pathology in frontal variant Alzheimer's disease. J. Alzheimers Dis. 39(1), 63–70 (2014).
    • 119 Johnson JK, Head E, Kim R et al. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch. Neurol. 56(10), 1233–1239 (1999).
    • 120 Lillo P, Mioshi E, Zoing MC et al. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph. Lateral Scler. 12(1), 45–51 (2011).
    • 121 Lomen-Hoerth C. Clinical phenomenology and neuroimaging correlates in ALS-FTD. J. Mol. Neurosci. 45(3), 656–662 (2011).
    • 122 Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59(7), 1077–1079 (2002).
    • 123 Pupillo E, Messina P, Logroscino G et al. Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann. Neurol. 75(2), 287–297 (2014).
    • 124 Lomen-Hoerth C, Murphy J, Langmore S et al. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60(7), 1094–1097 (2003).
    • 125 Murphy JM, Henry RG, Langmore S et al. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch. Neurol. 64(4), 530–534 (2007).
    • 126 Devenney E, Hornberger M, Irish M et al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol. 71(3), 31–39 (2014).
    • 127 Mesulam MM, Wieneke C, Thompson C et al. Quantitative classification of primary progressive aphasia at early and mild impairment stages. Brain 135(Pt 5), 1537–1553 (2012).
    • 128 Harris JM, Gall C, Thompson JC et al. Classification and pathology of primary progressive aphasia. Neurology 81(21), 1832–1839 (2013).
    • 129 Mesulam MM, Weintraub S, Rogalski EJ et al. Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Brain 137(Pt 4), 1176–1192 (2014).
    • 130 Rohrer JD, Caso F, Mahoney C et al. Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia. Brain Lang. 127(2), 121–126 (2013).
    • 131 Teichmann M, Kas A, Boutet C et al. Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation. Brain 136(Pt 11), 3474–3488 (2013).
    • 132 Henry ML, Gorno-Tempini ML. The logopenic variant of primary progressive aphasia. Curr. Opin Neurol. 23(6), 633–637 (2010).•• Summarizes current knowledge regarding the clinical symptoms, neuroanatomy, genetics and neuropathology associated with logopenic variant PPA.
    • 133 Nardell M, Tampi RR. Pharmacological treatments for frontotemporal dementias: a systematic review of randomized controlled trials. Am. J. Alzheimers Dis. Other Demen. 29(2), 123–132 (2014).
    • 134 Jicha GA. Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies. J. Mol. Neurosci. 45(3), 713–723 (2011).
    • 135 Ikeda M, Shigenobu K, Fukuhara R et al. Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. Dement. Geriatr. Cogn. Disord. 17(3), 117–121 (2004).
    • 136 Moretti R, Torre P, Antonello RM et al. Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms: a randomized, controlled, open 14-month study. Neurology 49(1), 13–19 (2003).
    • 137 Lebert F, Stekke W, Hasenbroekx C et al. Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement. Geriatr. Cogn. Disord. 17(4), 355–359 (2004).
    • 138 Moretti R, Torre P, Antonello R et al. Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients. Am. J. Alzheimers Dis. Other Demen. 18(4), 205–214 (2003).
    • 139 Curtis RC, Resch DS. Case of pick's central lobar atrophy with apparent stabilization of cognitive decline after treatment with risperidone. J. Clin. Psychopharmacol. 20(3), 384–385 (2000).
    • 140 Fellgiebel A, Muller MJ, Hiemke C et al. Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism. World J. Biol. Psychiatry 8(2), 123–126 (2007).
    • 141 Mendez MF, Shapira JS, Mcmurtray A et al. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am. J. Geriatr. Psychiatry 15(1), 84–87 (2007).
    • 142 Moretti R, Torre P, Antonello RM et al. Rivastigmine in frontotemporal dementia: an open-label study. Drugs Aging 21(14), 931–937 (2004).
    • 143 Kertesz A, Morlog D, Light M et al. Galantmine in frontotemporal dementia and primary progressive aphasia. Dement. Geriatr. Cogn. Disord. 25(2), 178–185 (2008).
    • 144 Vercelletto M, Boutoleau-Bretonniere C, Volteau C et al. Memantine in behavioral variant frontotemporal dementia: negative results. J. Alzheimers Dis. 23(4), 749–759 (2011).
    • 145 Boxer AL, Knopman DS, Kaufer DI et al. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 12(2), 149–156 (2013).
    • 146 Boxer AL, Gold M, Huey E et al. The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimers Dement. 9(2), 189–198 (2013).
    • 147 Boxer AL, Boeve BF. Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies. Alzheimer Dis. Assoc. Disord. 21(4), S79–S87 (2007).
    • 148 Mendez MF. Frontotemporal dementia: therapeutic interventions. Front. Neurol. Neurosci. 24, 168–178 (2009).
    • 149 De Vugt ME, Riedijk SR, Aalten P et al. Impact of behavioural problems on spousal caregivers: a comparison between Alzheimer's disease and frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 22(1), 35–41 (2006).
    • 150 Riedijk SR, De Vugt ME, Duivenvoorden HJ et al. Caregiver burden, health-related quality of life and coping in dementia caregivers: a comparison of frontotemporal dementia and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 22(5–6), 405–412 (2006).
    • 151 Boutoleau-Bretonniere C, Vercelletto M, Volteau C et al. Zarit burden inventory and activities of daily living in the behavioral variant of frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 25(3), 272–277 (2008).
    • 152 Mioshi E, Bristow M, Cook R et al. Factors underlying caregiver stress in frontotemporal dementia and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 27(1), 76–81 (2009).
    • 153 Mioshi E, Foxe D, Leslie F et al. The impact of dementia severity on caregiver burden in frontotemporal dementia and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 27(1), 68–73 (2013).
    • 154 Merrilees J, Hubbard E, Mastick J et al. Sleep in persons with frontotemporal dementia and their family caregivers. Nurs. Res. 63(2), 129–136 (2014).
    • 155 Merrilees J, Dowling GA, Hubbard E et al. Characterization of apathy in persons with frontotemporal dementia and the impact on family caregivers. Alzheimer Dis. Assoc. Disord. 27(1), 62–67 (2013).
    • 156 Barton C, Merrilees J, Ketelle R et al. Implementation of advanced practice nurse clinic for management of behavioral symptoms in dementia: a dyadic intervention (innovative practice). Dementia (London) 13(5), 686–696 (2014).
    • 157 Merrilees J. A model for management of behavioral symptoms in frontotemporal lobar degeneration. Alzheimer Dis. Assoc. Disord. 21(4), S64–69 (2007).
    • 158 Dowling GA, Merrilees J, Mastick J et al. Life enhancing activities for family caregivers of people with frontotemporal dementia. Alzheimer Dis. Assoc. Disord. 28(2), 175–181 (2013).
    • 159 Kortte K, Rogalski E. Behavioral interventions for enhancing life participation in behavioral variant frontotemporal dementia and primary progressive aphasia. Int. Rev. Psychiatry 25(2), 237–245 (2013).• Summarizes current knowledge and provides comprehensive recommendations for behavioral interventions in patients with FTD.
    • 160 Savage SA, Ballard KJ, Piguet O et al. Bringing words back to mind: improving word production in semantic dementia. Cortex 49(7), 1823–1832 (2013).
    • 161 The Association for Frontotemporal Degeneration. www.theaftd.org.
    • 162 Frontotemporal Dementia Research Group. www.ftdrg.org.
    • 163 Association for Frontotemporal Dementias. www.ftd-picks.org.
    • 164 Sapolsky D, Domoto-Reilly K, Negreira A et al. Monitoring progression of primary progressive aphasia: current approaches and future directions. Neurodegener. Dis. Manag. 1(1), 43–55 (2011).
    • 165 Perry DC, Kramer JH. Reward processing in neurodegenerative disease. Neurocase doi: 10.1080/13554794.2013.873063 (2014) (Epub ahead of print).
    • 166 Possin KL, Chester SK, Laluz V et al. The frontal-anatomic specificity of design fluency repetitions and their diagnostic relevance for behavioral variant frontotemporal dementia. J. Int. Neuropsychol. Soc. 18(5), 834–844 (2012).